Emplicure (EMPLI.ST) Stock Analysis & AI Equity Report
Emplicure (EMPLI.ST) overview
Emplicure (EMPLI.ST) stock analysis and AI equity research. For the latest completed financial year, 2022, Emplicure reported revenue of SEK 1.1m and operating profit of SEK -29.9m; the year-end share price was 0.94 SEK and market capitalisation was SEK 22.7m. Emplicure is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Emplicure's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
Figures updated on 2025-09-04. Data will be refreshed during report generation.
About Emplicure
Emplicure AB (publ) develops bioceramic-based products in two business areas: oral nicotine pouches and pharmaceutical pain treatment. The company uses its patented bioceramic platforms to create nicotine delivery products and to advance formulations built around existing and approved molecules and pharmaceutical ingredients. It is based in Uppsala, Sweden.
Generate the Emplicure report
Emplicure is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for Emplicure and represent the latest completed financial year (2022). See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.